AIDS in era of antiretrovirals

Confronting the deadly pandemic

An estimated 1 million people die each year from HIV/AIDS, while nearly 2 million people become newly infected with the virus.

Approximately 36.9 million people were living with the human immunodeficiency virus (HIV) at the end of 2017, the majority of them in sub-Saharan Africa. While there is no cure for HIV/AIDS, a combination of drugs, known as antiretrovirals (ARVs), enable people to live longer, healthier lives. The cost of first-line drugs are now cheaper than ever, but efforts are still needed to ensure everyone who is living with HIV receives treatment. Over 15 million people missed out on receiving treatment in 2017.

 
Website

MSF Access Campaign

msfaccess.org

Quick Facts

 
HIV/AIDS

AIDS triple therapy for less than $1 per day

Press Release 7 Feb 2001
 
HIV/AIDS

Offer to Africa On AIDS Drug

Press Release 7 Feb 2001
 
HIV/AIDS

US action at WTO threatens Brazil's successful Aids programme

Press Release 1 Feb 2001
 
HIV/AIDS

MSF basic information

Project Update 1 Jan 2001
 
HIV/AIDS

MSF says pharmaceutical industry must keep its promise

Project Update 5 Dec 2000
 
HIV/AIDS

The crippled continent

Project Update 2 Dec 2000
 
HIV/AIDS

Glaxo stops Africans buying cheap Aids drugs

Project Update 2 Dec 2000
 
HIV/AIDS

"Treatment exists, but at unaffordable prices for most of the patients"

Project Update 1 Dec 2000
 
HIV/AIDS

WHO's "massive effort" is not aggressive enough, says MSF

Press Release 4 Oct 2000
fieldresearch.msf.org

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. Read all our HIV/AIDS-related articles on our dedicated Field Research website.

Visit site
Advanced HIV management in Homa Bay